256956-42-0 3-(4-(Bromomethyl)phenyl)-5-methyl-1,2,4-oxadiazole

Introduction

CAS No. :	256956-42-0	MDL No. :	MFCD00020808
Formula :	C10H9BrN2O	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	BMXSEDLZMUPKSH-UHFFFAOYSA-N
M.W :	253.10	Pubchem ID :	7164590
Synonyms :

Physicochemical Properties

Num. heavy atoms :	14
Num. arom. heavy atoms :	11
Fraction Csp3 :	0.2
Num. rotatable bonds :	2
Num. H-bond acceptors :	3.0
Num. H-bond donors :	0.0
Molar Refractivity :	57.54
TPSA :	38.92 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	Yes
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.76 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.72
Log Po/w (XLOGP3) :	2.93
Log Po/w (WLOGP) :	2.79
Log Po/w (MLOGP) :	1.99
Log Po/w (SILICOS-IT) :	3.36
Consensus Log Po/w :	2.76

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.7
Solubility :	0.05 mg/ml ; 0.000197 mol/l
Class :	Soluble
Log S (Ali) :	-3.41
Solubility :	0.0987 mg/ml ; 0.00039 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-5.03
Solubility :	0.00235 mg/ml ; 0.00000929 mol/l
Class :	Moderately soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	1.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	2.57

Signal Word:	Danger	Class:	8
Precautionary Statements:	P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501	UN#:	3261
Hazard Statements:	H302-H314	Packing Group:	Ⅱ
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine